Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2020BMJ Neurology OpenOpen Access

Cognitive effects of onabotulinumtoxinA in chronic migraine

View Full Paper
Ask AI
Bookmark
Share

Authors

SHS. HoDDDavid DarbyNBNatasha Bear

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ho et al. (2020) studied this question.

synapsesocial.com/papers/6a7d3277c7e6f6a50737d0afhttps://doi.org/10.1136/bmjno-2019-000014
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cognitive Disturbances and Regional Cerebral Blood Flow Abnormalities in Migraine Patients: Their Relationship with the Clinical Manifestations of the Illness2002 · 199 citations
  2. 2Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study2018 · 198 citations
  3. 3Memory Disturbances in Migraine With and Without Aura: A Strategy Problem?2000 · 126 citations
  4. 4Reversible Cognitive Decline Accompanies Migraine and Cluster Headaches2000 · 87 citations
  5. 5Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)2010 · 649 citations